Order Careers Contact Us Sign in Adaptive Biotechnologies Order Careers
Contact Us Sign in Immune Profiling Platform Platform OverviewPublications
Products & Services LIFE SCIENCES RESEARCHimmunoSEQ®CLINICAL
DIAGNOSTICSclonoSEQ®PipelineDRUG DISCOVERYCellular TherapyVaccines
PARTNERSHIPS Cancer Cellular TherapyAntigen MapBiopharma PartnershipsStrategic
Collaborators About Us Our StoryCultureCareersNewsroomContact Us About Us
Newsroom Press News Features Events Contact Media Relations TOP PRESS RELEASES
01/04/2019 Adaptive Biotechnologies to Enter Into Worldwide Collaboration and
License Agreement with Genentech to Develop Personalized Cellular Therapies
for the Treatment of Cancer 01/03/2019 Adaptive Biotechnologies to Present at
the 37th Annual J.P. Morgan Healthcare Conference 09/28/2018 FDA Grants De
Novo Designation for Adaptive Biotechnologies’ clonoSEQ Assay to Detect and
Monitor Minimal Residual Disease (MRD) in Patients with Multiple Myeloma and
Acute Lymphoblastic Leukemia LATEST PRESS RELEASES 02/13/2013 Sequenta
Launches ClonoSIGHT, First Sequencing-based Minimal Residual Disease Test for
Leukemia and Lymphoma 01/22/2013 Adaptive makes national impact at American
Society of Hematology (ASH) conference 12/14/2012 Collaborators Present Data
Supporting Use of Sequenta’s LympoSIGHT Method for Acute Lymphoblastic
Leukemia 12/06/2012 Adaptive launches clonoSEQ, a more sensitive, accurate
assay to detect MRD in blood-based cancers 12/05/2012 Adaptive Biotechnologies
to Present Data at ASH 2012 Demonstrating Clinical Significance of Next-
Generation Sequencing 10/16/2012 Clinical Study Validates Sequenta’s
LymphoSIGHT Platform as More Sensitive Alternative to Flow Cytometry for
Cancer Detection 10/05/2012 Adaptive Biotechnologies Hires Former Senior Amgen
Executive and National Institutes of Health Veteran Ilan “Lanny” Kirsch, M.D.
09/05/2012 New study using immunoSEQ provides significant clues to eventual
vaccine for HIV 09/05/2012 Adaptive CEO Robins Honored with 40 Under 40 Award
Previous 1 … 12 13 14 15 Next TOP NEWS FEATURES 01/04/2019 Genentech: A New
Age for Neoantigens 01/03/2019 Microsoft Blog: Every immune system has a story
to tell; the key is knowing how to listen 05/09/2018 T Cell Receptor
Sequencing IDs Aggressive Lymphoma Subtype LATEST NEWS FEATURES TOP EVENTS
01/03/2019 J.P. Morgan Healthcare Conference 2019 12/01/2018 ASH 2018 LATEST
EVENTS Contact media relations phone (917) 912-7195 email
media@adaptivebiotech.com Corporate/Research (855) 466-8667 Diagnostics (888)
522-8988 Immune Profiling PlatformPlatform Overview Publications Products &
ServicesLIFE SCIENCES RESEARCH immunoSEQ® CLINICAL DIAGNOSTICS clonoSEQ®
Pipeline DRUG DISCOVERY Cellular Therapy Vaccines PartnershipsCancer Cellular
Therapy Antigen Map Biopharma Partnerships Strategic Collaborators About UsOur
Story Culture Careers News & Events Contact Us © Adaptive Biotechnologies. All
Rights Reserved. Terms of Use Online Privacy Policy Privacy Shield Policy
HIPAA Policy Code of Conduct Patents & Trademarks Licenses